Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Up-front ctDNA Analysis Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - the Lungmarker² Study

NCT06105177 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.

NCT NCT06105177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06105177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Up-front ctDNA Analysis Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - the Lungmarker² Study
Lead sponsor
Catharina Ziekenhuis Eindhoven
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2023
Completion date
October 31, 2026
Enrollment
800 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer